30
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Progressive impairment of Ca V1.1 function in the skeletal muscle of mice expressing a mutant type 1 Cu/Zn superoxide dismutase (G93A) linked to amyotrophic lateral sclerosis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disorder that is typically fatal within 3–5 years of diagnosis. While motoneuron death is the defining characteristic of ALS, the events that underlie its pathology are not restricted to the nervous system. In this regard, ALS muscle atrophies and weakens significantly before presentation of neurological symptoms. Since the skeletal muscle L-type Ca 2+ channel (Ca V1.1) is a key regulator of both mass and force, we investigated whether Ca V1.1 function is impaired in the muscle of two distinct mouse models carrying an ALS-linked mutation.

          Methods

          We recorded L-type currents, charge movements, and myoplasmic Ca 2+ transients from dissociated flexor digitorum brevis (FDB) fibers to assess Ca V1.1 function in two mouse models expressing a type 1 Cu/Zn superoxide dismutase mutant (SOD1 G93A).

          Results

          In FDB fibers obtained from “symptomatic” global SOD1 G93A mice, we observed a substantial reduction of SR Ca 2+ release in response to depolarization relative to fibers harvested from age-matched control mice. L-type current and charge movement were both reduced by ~40 % in symptomatic SOD1 G93A fibers when compared to control fibers. Ca 2+ transients were not significantly reduced in similar experiments performed with FDB fibers obtained from “early-symptomatic” SOD1 G93A mice, but L-type current and charge movement were decreased (~30 and ~20 %, respectively). Reductions in SR Ca 2+ release (~35 %), L-type current (~20 %), and charge movement (~15 %) were also observed in fibers obtained from another model where SOD1 G93A expression was restricted to skeletal muscle.

          Conclusions

          We report reductions in EC coupling, L-type current density, and charge movement in FDB fibers obtained from symptomatic global SOD1 G93A mice. Experiments performed with FDB fibers obtained from early-symptomatic SOD1 G93A and skeletal muscle autonomous MLC/SOD1 G93A mice support the idea that events occurring locally in the skeletal muscle contribute to the impairment of Ca V1.1 function in ALS muscle independently of innervation status.

          Electronic supplementary material

          The online version of this article (doi:10.1186/s13395-016-0094-6) contains supplementary material, which is available to authorized users.

          Related collections

          Most cited references42

          • Record: found
          • Abstract: found
          • Article: not found

          Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

          Mutations of human Cu,Zn superoxide dismutase (SOD) are found in about 20 percent of patients with familial amyotrophic lateral sclerosis (ALS). Expression of high levels of human SOD containing a substitution of glycine to alanine at position 93--a change that has little effect on enzyme activity--caused motor neuron disease in transgenic mice. The mice became paralyzed in one or more limbs as a result of motor neuron loss from the spinal cord and died by 5 to 6 months of age. The results show that dominant, gain-of-function mutations in SOD contribute to the pathogenesis of familial ALS.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Skeletal muscle is a primary target of SOD1G93A-mediated toxicity.

            The antioxidant enzyme superoxide dismutase 1 (SOD1) is a critical player of the antioxidative defense whose activity is altered in several chronic diseases, including amyotrophic lateral sclerosis. However, how oxidative insult affects muscle homeostasis remains unclear. This study addresses the role of oxidative stress on muscle homeostasis and function by the generation of a transgenic mouse model expressing a mutant SOD1 gene (SOD1(G93A)) selectively in skeletal muscle. Transgenic mice developed progressive muscle atrophy, associated with a significant reduction in muscle strength, alterations in the contractile apparatus, and mitochondrial dysfunction. The analysis of molecular pathways associated with muscle atrophy revealed that accumulation of oxidative stress served as signaling molecules to initiate autophagy, one of the major intracellular degradation mechanisms. These data demonstrate that skeletal muscle is a primary target of SOD1(G93A) -mediated toxicity and disclose the molecular mechanism whereby oxidative stress triggers muscle atrophy.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The "dying-back" phenomenon of motor neurons in ALS.

              Amyotrophic lateral sclerosis (ALS) is a lethal disease, characterized by progressive death of motor neurons with unknown etiology. Evidence from animal models indicates that neuronal dysfunction precedes the clinical phase of the disease. However, in parallel extensive nerve sprouting and synaptic remodeling as part of a compensatory reinnervation processes and possibly also of motor neurons pathology was demonstrated. Therefore, the weakness in muscle groups will not be clinically apparent until a large proportion of motor units are lost. This motor unit loss and associated muscle function which precedes the death of motor neurons may resemble the "die-back" phenomena. Studies indicated that in the early stages the nerve terminals and motor neuron junctions are partially degraded while the cell bodies in the spinal cord are mostly intact. Treatments to rescue motor neurons according to "dying-forward" model of motor neuron pathology in ALS have shown only limited success in SOD1(G93A) transgenic mice as well as in humans. If cell body degeneration is late compared with axonal degeneration, early intervention could potentially prevent loss of motor neurons. Therefore, it should be considered, according to the dying back hypothesis, to focus on motor neurons terminals in order to delay or prevent the progressive degradation.
                Bookmark

                Author and article information

                Contributors
                donald.beqollari@ucdenver.edu
                christin.romberg@ucdenver.edu
                gabriella.dobrowolny@uniroma1.it
                martina.martini@uniroma1.it
                andrew.voss@wright.edu
                antonio.musaro@uniroma1.it
                roger.bannister@ucdenver.edu
                Journal
                Skelet Muscle
                Skelet Muscle
                Skeletal Muscle
                BioMed Central (London )
                2044-5040
                23 June 2016
                23 June 2016
                2016
                : 6
                : 24
                Affiliations
                [ ]Department of Medicine-Cardiology Division, University of Colorado School of Medicine, 12700 East 19th Avenue, B-139, Aurora, CO 80045 USA
                [ ]Institute Pasteur Cenci-Bolognetti, DAHFMO-Unit of Histology and Medical Embryology, La Sapienza University, Via A. Scarpa, 14, 00161 Rome, Italy
                [ ]Center for Life Nano Science@Sapienza, Istituto Italiano di Tecnologia, Rome, Italy
                [ ]Department of Biological Sciences, College of Science and Mathematics, Wright State University, 235A Biological Sciences, 3640 Colonel Glenn Highway, Dayton, OH 45435 USA
                Article
                94
                10.1186/s13395-016-0094-6
                4918102
                27340545
                21bb2bba-9bae-4b43-bf0d-1052922ead19
                © The Author(s). 2016

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 1 October 2015
                : 3 June 2016
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100005508, Boettcher Foundation (US);
                Funded by: FundRef http://dx.doi.org/10.13039/100001441, Judith and Jean Pape Adams Charitable Foundation (US);
                Funded by: FundRef http://dx.doi.org/10.13039/100000049, National Institute on Aging (US);
                Award ID: 2T32AG000279-11
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100002426, Fondazione Telethon;
                Funded by: Fondazione Roma
                Categories
                Research
                Custom metadata
                © The Author(s) 2016

                Rheumatology
                amyotrophic lateral sclerosis,als,cav1.1,excitation-contraction coupling,l-type,skeletal muscle,sod1,neuromuscular disease

                Comments

                Comment on this article